Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 12/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 11/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.38 |
| ▸ | NPC1 | O15118 | 11/20 | 0.38 |
| ▸ | HPGD | P15428 | 10/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.38 |
| ▸ | TP53 | P04637 | 7/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 6/20 | 0.35 |
| ▸ | CASP3 | P42574 | 3/20 | 0.35 |
| ▸ | SENP8 | Q96LD8 | 3/20 | 0.35 |
| ▸ | SENP7 | Q9BQF6 | 3/20 | 0.35 |
| ▸ | SENP6 | Q9GZR1 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 5/20 | 0.34 |
| ▸ | NFKB2 | Q00653 | 5/20 | 0.34 |
| ▸ | RELA | Q04206 | 5/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2143446 | 0.87 | MAPT (0.35) | RAB9ASMN1; SMN2KDM4EALDH1A1NPC1 | |
| SCHEMBL6018363 | 0.87 | MAPT (0.35) | RAB9ASMN1; SMN2KDM4EALDH1A1NPC1 | |
| SCHEMBL14081253 | 0.81 | RAB9A (0.35) | RAB9ASMN1; SMN2KDM4EALDH1A1NPC1 | |
| SCHEMBL12744353 | 0.74 | PFKFB3 (0.30) | — | |
| SCHEMBL13324946 | 0.73 | PFKFB3 (0.30) | — | |
| SCHEMBL3159352 | 0.73 | NPC1 (0.38) | RAB9ASMN1; SMN2KDM4EALDH1A1NPC1 | |
| SCHEMBL13607204 | 0.73 | MEN1 (0.37) | RAB9AKDM4EALDH1A1NPC1HPGD | |
| SCHEMBL14156799 | 0.73 | MEN1 (0.30) | MAPTL3MBTL1MEN1KMT2A | |
| SCHEMBL10021911 | 0.73 | MAPT (0.32) | TP53MAPTL3MBTL1MEN1KMT2A | |
| SCHEMBL13950686 | 0.72 | PDK2 (0.34) | ALDH1A1HSD17B10LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120241683-A1 | Dihalogen Indolocarbazole Monomers and Poly(Indolocarbazoles) | LG CHEM, LTD. (KR) | 2012-09-27 | — | — | US | claimed |
| US-20110060097-A1 | Dihalogen Indolocarbazole Monomers and Poly (Indolocarbazoles) | LG CHEM, LTD. (KR) | 2011-03-10 | — | — | US | claimed |
| US-8362275-B2 | Dihalogen indolocarbazole monomers and poly(indolocarbazoles) | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-29 | — | — | US | disclosed |
| US-20120241683-A1 | Dihalogen Indolocarbazole Monomers and Poly(Indolocarbazoles) | LG CHEM, LTD. (KR) | 2012-09-27 | — | — | US | disclosed |
| US-8217181-B2 | Dihalogen indolocarbazole monomers and poly (indolocarbazoles) | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-07-10 | — | — | US | disclosed |
| US-20110060097-A1 | Dihalogen Indolocarbazole Monomers and Poly (Indolocarbazoles) | LG CHEM, LTD. (KR) | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110060097-A1 | Dihalogen Indolocarbazole Monomers and Poly (Indolocarbazoles) | PARG, DDT, MDM4 | RAB9A 4741/4885SMN1; SMN2 4715/4885KDM4E 2657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.